Both approaches have evidence supporting them this RCT provides the strongest clinical evidence, while the 2021 Pamela R.D
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
Standard protocols use 1-4mg daily, representing a margin of safety exceeding 5,000-fold
Some people feel slightly better within a few days, while others notice gradual improvement over one to two weeks
Provides Antioxidant & Anti-Inflammatory Protection As a powerful antioxidant , GHK-Cu protects skin cells from environmental damage, pollution, and UV exposure